News

AstraZeneca's CEO said the company has proposed U.S. price cuts to some drugs, while Doximity enters competitive AI scribing ...
The pharmaceutical giant said second-quarter revenue increased to $14.46 billion from $12.94 billion. U.S. revenue was up 13% ...
Seasoned communications leader Rikki Jones joins biopharmaceutical giant AstraZeneca as Head of Communications, International ...
Investors were clearly impressed by the company's second-quarter beats, especially the one on the bottom line.
AstraZeneca Plc reported better-than-expected sales and rising profit for the second quarter, spurred by its stable of cancer ...
For many rare disease patients and their families, this often results in years of uncertainty, misdiagnosis, and limited or ...
Pascal Soriot's comments came during AstraZeneca's Q2 earnings call in regard to President Donald Trump’s newly announced ...
In a vote of confidence for Virginia’s growing life sciences sector, pharmaceutical giant AstraZeneca announced plans to ...
STV Group, the Scottish media firm, has dropped as much as 33% after its profit warning. A tough advertising market is ...
British biopharmaceutical giant AstraZeneca plans to invest $50 billion in the United States by 2030, expanding its presence ...
AstraZeneca beat second-quarter earnings expectations on Tuesday, helped by strong sales of key cancer, heart and kidney ...